Helen L. Pilmore

ORCID: 0000-0003-1069-9487
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and Medication Impact
  • Renal Transplantation Outcomes and Treatments
  • Dialysis and Renal Disease Management
  • Potassium and Related Disorders
  • Renal Diseases and Glomerulopathies
  • Acute Myocardial Infarction Research
  • Polyomavirus and related diseases
  • Heart Failure Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Cardiac Imaging and Diagnostics

Auckland City Hospital
2020-2024

University of Auckland
2020-2024

Introduction. Home dialysis modalities offer several clinical and economic benefits compared to facility-based treatment in patients with kidney failure. Studies have shown that sex socioeconomic status (SES) disparities exist access transplantation failure, but whether similar occur the home after transplant failure is unknown. Methods. Using data from ANZDATA registry, who commenced Australia were included (2000-2020). The associations between uptake of peritoneal (PD) haemodialysis (HHD)...

10.1159/000543788 article EN American Journal of Nephrology 2025-02-26

Abstract Aims Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular (CVD). We examined the characteristics, management and outcomes patients CKD in All New Zealand Acute Coronary Syndrome Quality Improvement (ANZACS‐QI) national registry. Methods The cohort comprised (NZ) acute coronary syndrome undergoing angiography between January 2013 December 2016. Patients were categorized according to their stage CKD. Outcomes included all‐cause cause‐specific mortality...

10.1111/nep.13703 article EN Nephrology 2020-02-27

Abstract Aim Determining specific causes of allograft failure allows a focus on understanding and treating these conditions. Previous studies highlight chronic antibody‐mediated rejection as leading cause late failure. We sought to define in large cohort kidney transplant recipients across multiple centres Australia New Zealand, including cases previously attributed nephropathy (CAN). Methods All death‐censored failures at 9 participating between 1 January 2014 31 December 2018 were...

10.1111/nep.14397 article EN cc-by-nc Nephrology 2024-09-30

Background. Recurrent glomerulonephritis (GN) is an important cause of allograft loss after transplantation when GN the primary kidney failure. Retransplantation from recurrent disease requires careful consideration. We aimed to determine probability relisting and risk retransplantation in recipients with prior GN. Methods. Using data Australia New Zealand Dialysis Transplant Registry multivariable Cox modeling, we compared waitlisting second between those without disease. Results. Of 3276...

10.1097/txd.0000000000001717 article EN cc-by-nc-nd Transplantation Direct 2024-10-18

The association of smoking with new-onset cardiovascular disease, chronic lung malignancy and mortality in dialysis is well-known. prevalence its clinical outcome was assessed.Multicentre cohort study using 'ANZDATA' Registry, 57 838 adults who commenced (>3 months) between 1990 2016 were included. Patients' demographics, initial modality, presence comorbidities history are predictors. primary all-cause mortality. Secondary outcomes prevalence, cause-specific mortality, non-skin cancers,...

10.1111/nep.14122 article EN Nephrology 2022-10-12
Coming Soon ...